An Efficacy Study of Paliperidone for the Prevention of Relapse in Participants With Schizophrenia
Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy, tolerability and safety of
paliperidone extended release (ER) tablets (between 3 to 12 milligram (mg), once a day) in
the prevention of relapse in schizophrenia participants.